These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 166481)

  • 41. Tocofibrate (tocopheryl 2-(p-chlorophenoxy) isobutyrate); a new peroxisomotropic compound, and its hypocholesterolemic activity in cholesterol-fed rats.
    Tsurute S; Kibata M; Takano T
    Gen Pharmacol; 1982; 13(4):309-13. PubMed ID: 7129071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of triton WR-1339 on peroxisomal enzymes of rat liver.
    Ishii H; Suga T; Hayashi H; Niinobe S
    Biochim Biophys Acta; 1979 Jan; 582(2):213-20. PubMed ID: 32918
    [No Abstract]   [Full Text] [Related]  

  • 43. The effects of clofibrate ingestion on alveolar macrophage peroxisome content and oxygen metabolism.
    Drath DB; Davies P; Shorrey JM; Simpson P
    Agents Actions; 1982 Jul; 12(3):365-70. PubMed ID: 6291347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Properties of peroxisomes and their induction by clofibrate in normal adult rat hepatocytes in primary culture.
    Furukawa K; Mochizuki Y; Sawada N
    In Vitro; 1984 Jul; 20(7):573-84. PubMed ID: 6469275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Peroxisomes and hypolipidemic agents ].
    Heller F; Pourbaix S
    Sem Hop; 1982 Jul; 58(28-29):1712-7. PubMed ID: 6289453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic enzymes, CoASH and long-chain acyl-CoA in subcellular fractions as affected by drugs inducing peroxisomes and smooth endoplasmic reticulum.
    Berge RK; Aarsland A; Bakke OM; Farstad M
    Int J Biochem; 1983; 15(2):191-204. PubMed ID: 6130010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in peroxisomes in preneoplastic liver and hepatoma of mice induced by alpha-benzene hexachloride.
    Tsukada H; Gotoh M; Mochizuki Y; Furukawa K
    Cancer Res; 1979 May; 39(5):1628-34. PubMed ID: 85485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic effect of two hypolipidemic drugs in rats.
    Magnusson G; Magnusson O
    Exp Pathol (Jena); 1977; 13(2-3):180-7. PubMed ID: 913535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunocytochemical analysis of soluble epoxide hydrolase and catalase in mouse and rat hepatocytes demonstrates a peroxisomal localization before and after clofibrate treatment.
    Hollinshead M; Meijer J
    Eur J Cell Biol; 1988 Aug; 46(3):394-402. PubMed ID: 3181162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytochemical localization of peroxidatic activity of catalase in rat hepatic microbodies (peroxisomes).
    Fahimi HD
    J Cell Biol; 1969 Nov; 43(2):275-88. PubMed ID: 4186511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of selected hypolipidemic drugs on cell ultrastructure.
    Svoboda DJ; Azarnoff DL
    Fed Proc; 1971; 30(3):841-7. PubMed ID: 5575296
    [No Abstract]   [Full Text] [Related]  

  • 52. Ultrastructural alterations of hepatic microbodies.
    Hruban Z; Swift H; Slesers A
    Lab Invest; 1966 Dec; 15(12):1884-901. PubMed ID: 4289682
    [No Abstract]   [Full Text] [Related]  

  • 53. Formation of 8-oxodeoxyguanosine in liver DNA and hepatic injury by peroxisome proliferator clofibrate and perfluorodecanoic acid in rats.
    Kim SC; Hong JT; Jang SJ; Kang WS; Yoo HS; Yun YP
    J Toxicol Sci; 1998 May; 23(2):113-9. PubMed ID: 9644651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643.
    Reddy JK; Azarnoff DL; Sirtori CR
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):4-14. PubMed ID: 708142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of some hypocholesterolemic agents on hepatic ulrastructure and microbody enzymes.
    Hruban Z; Mochizuki Y; Goto M; Slesers A; Chou SH
    Lab Invest; 1974 Apr; 30(4):474-85. PubMed ID: 4150963
    [No Abstract]   [Full Text] [Related]  

  • 56. Pyruvate inhibits clofibrate-induced hepatic peroxisomal proliferation and free radical production in rats.
    Stanko RT; Sekas G; Isaacson IA; Clarke MR; Billiar TR; Paul HS
    Metabolism; 1995 Feb; 44(2):166-71. PubMed ID: 7869911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of clofibrate on intracellular enzyme distribution in the rat liver].
    Panchenko LF; Popova SV; Pirozhkov SV; Antonenkov VD
    Tsitologiia; 1983 Nov; 25(11):1302-8. PubMed ID: 6659071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stimulation of catalase synthesis and increase of carnitine acetyltransferase activity in the liver of intact female rats fed clofibrate.
    Reddy JK; Kumar NS
    J Biochem; 1979 Mar; 85(3):847-56. PubMed ID: 429267
    [No Abstract]   [Full Text] [Related]  

  • 59. New observations on microbodies. A cytochemical study on CPIB-treated rat liver.
    Legg PG; Wood RL
    J Cell Biol; 1970 Apr; 45(1):118-29. PubMed ID: 5458991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The involvement of selenium in peroxisome proliferation caused by dietary administration of clofibrate to rats.
    Olsson U; Garberg P; Lundgren B; Andersson K; Hultenby K; Bergstrand A; Eriksson AM; Högberg J; DePierre JW
    Chem Biol Interact; 1992 Nov; 85(1):49-67. PubMed ID: 1458550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.